Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Bictegravir/Emtricitabine/Tenofovir Alafenamide in a Multicentre Cohort: Real-Life Experience From Spain.
Ann Pharmacother. 2024 Feb;58(2):140-147. doi: 10.1177/10600280231168852. Epub 2023 May 2.
Ann Pharmacother. 2024.
PMID: 37131300
Impact of interferon-free therapies in HIV/HCV co-infected patients on real clinical practice: results from a multicenter region-wide cohort study (2014-2018).
Rial-Crestelo D, Sepúlveda MA, González-Gasca FJ, Geijo-Martínez P, Martínez-Alfaro E, Barberá JR, Yzusqui M, Casallo S, García M, Muñoz Hornero C, Espinosa-Gimeno A, Torralba M; Grupo de Estudio de Castilla la Manche de enfermedades Infecciosas (GECMEI).
Rial-Crestelo D, et al. Among authors: gonzalez gasca fj.
Eur J Gastroenterol Hepatol. 2021 Feb 1;32(2):279-287. doi: 10.1097/MEG.0000000000002012.
Eur J Gastroenterol Hepatol. 2021.
PMID: 33252415
Item in Clipboard
Effectiveness of direct-acting antiviral therapy in patients with a HCV/HIV coinfection. A multicenter cohort study.
Rial-Crestelo D, Rodríguez-Cola M, González-Gasca FJ, Geijo-Martínez P, Belinchón-Moya O, Martínez-Alfaro E, Mateos-Rodríguez F, Barberá JR, Yzusqui M, Casallo S, García M, Espinosa-Gimeno A, Torralba M.
Rial-Crestelo D, et al. Among authors: gonzalez gasca fj.
Rev Esp Enferm Dig. 2018 Jan;110(1):35-43. doi: 10.17235/reed.2017.5210/2017.
Rev Esp Enferm Dig. 2018.
PMID: 29271221
Free article.
Item in Clipboard
Does fibrosis really regress in HIV/hepatitis C virus co-infected patients after treatment with direct antiviral agents?
Rial-Crestelo D, Sepúlveda MA, González-Gasca FJ, Geijo-Martínez P, Martínez-Alfaro E, Barberá JR, Yzusqui M, Casallo S, García M, Hornero CM, Espinosa-Gimeno A, Torralba M.
Rial-Crestelo D, et al. Among authors: gonzalez gasca fj.
AIDS. 2020 Mar 1;34(3):427-432. doi: 10.1097/QAD.0000000000002433.
AIDS. 2020.
PMID: 31996593
Item in Clipboard
Aprotinin treatment against SARS-CoV-2: A randomized phase III study to evaluate the safety and efficacy of a pan-protease inhibitor for moderate COVID-19.
Redondo-Calvo FJ, Padín JF, Muñoz-Rodríguez JR, Serrano-Oviedo L, López-Juárez P, Porras Leal ML, González Gasca FJ, Rodríguez Martínez M, Pérez Serrano R, Sánchez Cadena A, Bejarano-Ramírez N, Muñoz Hornero C, Barberá Farré JR, Domínguez-Quesada I, Sepúlveda Berrocal MA, Villegas Fernández-Infantes MD, Manrique Romo MI, Parra Comino Á, Pérez-Ortiz JM, Gómez-Romero FJ; ATAC team.
Redondo-Calvo FJ, et al. Among authors: gonzalez gasca fj.
Eur J Clin Invest. 2022 Jun;52(6):e13776. doi: 10.1111/eci.13776. Epub 2022 Apr 5.
Eur J Clin Invest. 2022.
PMID: 35342931
Free PMC article.
Clinical Trial.
Item in Clipboard
A multicenter randomized open-label clinical trial for convalescent plasma in patients hospitalized with COVID-19 pneumonia.
Avendaño-Solá C, Ramos-Martínez A, Muñez-Rubio E, Ruiz-Antorán B, Malo de Molina R, Torres F, Fernández-Cruz A, Calderón-Parra J, Payares-Herrera C, Díaz de Santiago A, Romera-Martínez I, Pintos I, Lora-Tamayo J, Mancheño-Losa M, Paciello ML, Martínez-González AL, Vidán-Estévez J, Nuñez-Orantos MJ, Saez-Serrano MI, Porras-Leal ML, Jarilla-Fernández MC, Villares P, de Oteyza JP, Ramos-Garrido A, Blanco L, Madrigal-Sánchez ME, Rubio-Batllés M, Velasco-Iglesias A, Paño-Pardo JR, Moreno-Chulilla JA, Muñiz-Díaz E, Casas-Flecha I, Pérez-Olmeda M, García-Pérez J, Alcamí J, Bueno JL, Duarte RF; ConPlas-19 Study Group.
Avendaño-Solá C, et al.
J Clin Invest. 2021 Oct 15;131(20):e152740. doi: 10.1172/JCI152740.
J Clin Invest. 2021.
PMID: 34473652
Free PMC article.
Clinical Trial.
Item in Clipboard
High vancomycin minimum inhibitory concentration is associated with poor outcome in patients with methicillin-susceptible Staphylococcus aureus bacteremia regardless of treatment.
Castón JJ, González-Gasca F, Porras L, Illescas S, Romero MD, Gijón J.
Castón JJ, et al.
Scand J Infect Dis. 2014 Nov;46(11):783-6. doi: 10.3109/00365548.2014.931596. Epub 2014 Aug 19.
Scand J Infect Dis. 2014.
PMID: 25134647
Item in Clipboard
Interferon-γ production by CMV-specific CD8+ T lymphocytes provides protection against cytomegalovirus reactivation in critically ill patients.
Castón JJ, Cantisán S, González-Gasca F, Páez-Vega A, Abdel-Hadi H, Illescas S, Alonso G, Torre-Cisneros J.
Castón JJ, et al.
Intensive Care Med. 2016 Jan;42(1):46-53. doi: 10.1007/s00134-015-4077-6. Epub 2015 Nov 4.
Intensive Care Med. 2016.
PMID: 26537489
Item in Clipboard
Cite
Cite